What Is MOTS-c?
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a short, 16-amino-acid signaling peptide encoded by a small open reading frame within the mitochondrial 12S ribosomal RNA gene; it acts as a mitokine that influences skeletal-muscle metabolic signaling, reportedly through inhibition of the folate cycle and linked de novo purine biosynthesis, which leads to AMPK activation and improved insulin sensitivity in preclinical models. First characterized in 2015, MOTS-c belongs to the emerging family of mitochondrial-derived peptides (MDPs) produced by the mitochondrial genome itself. It is a research reagent with no approved human indication; this overview covers molecular biology, family context and experimental design, not use recommendations.
Discovery and Core Mechanism
The foundational study (Lee and colleagues, Cell Metabolism, 2015; PMID 25738459) identified the sORF in mitochondrial 12S rRNA encoding the 16-residue peptide. Key reported findings:
- Primary target tissue: skeletal muscle.
- Cellular action: modulation of folate-cycle and purine-biosynthesis intermediates, converging on AMPK activation.
- In mice, MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance as well as diet-induced obesity.
Citable conclusion 1: MOTS-c reframed mitochondria not merely as energy factories but as signaling organelles that encode regulatory peptides; the 2015 study linked a mitochondrial transcript directly to systemic metabolic homeostasis in mouse models (PMID 25738459).
The Mitochondrial-Derived Peptide Family
MOTS-c should not be discussed in isolation. The MDP family includes:
- Humanin, the first discovered MDP, originally linked to neuronal survival and later to metabolic and inflammatory roles;
- SHLP2/SHLP3, small humanin-like peptides derived from the same mitochondrial rRNA region;
- MOTS-c, the 12S-rRNA-derived member focused here.
Family members differ in gene location, receptor biology and primary phenotype; a researcher comparing them should avoid assuming a shared mechanism. Commentaries on MOTS-c (PMC6462348) note that rodent exercise-mimetic signals have not been matched by interventional human data, with human evidence largely observational.
Exercise-Mimetic Signaling: What the Data Support
AMPK activation overlaps the metabolic adaptation triggered by endurance exercise: increased glucose uptake, oxidative substrate use and mitochondrial gene expression. MOTS-c’s reported ability to shift muscle metabolism toward this program earned it the exercise-mimetic label in preclinical discussion. Two cautions keep the label honest:
- Species gap. The strongest efficacy data are mouse studies; human interventional trials are not established.
- Pathway overlap with drugs. AICAR activates AMPK through ZMP signaling, while MOTS-c reaches AMPK via folate/purine-linked effects; parallel experiments can compare route-specific outcomes but should not assume equivalence.
Citable conclusion 2: MOTS-c’s evidence base supports a mitochondrial-to-nuclear metabolic signaling axis in rodents; the gap between model phenotypes and clinical outcomes mirrors the broader MDP field, where mechanism is clearer than therapeutic efficacy (PMC6462348; PMID 25738459).
Assay Design for MOTS-c Research
- Metabolic readouts. Glucose uptake, insulin-stimulated Akt/GLUT4 proxies, fatty-acid oxidation markers and AMPK phosphorylation are aligned with the reported mechanism.
- Folate/purine intermediates. Where analytical capacity exists, measure pathway metabolites rather than inferring mechanism from body-weight changes alone.
- Tissue choice. Skeletal muscle and metabolic tissues are the expected target organs; generic cell lines may underperform without appropriate metabolic context.
- Controls and duration. Include vehicle, untreated and pathway-reference arms; distinguish acute signaling from chronic metabolic outcomes.
For a membrane-focused mitochondrial tool, SS-31 complements MOTS-c at a different mitochondrial layer; the research MOTS-c product page lists specifications and QC documentation.
Quality and Handling Notes
- Verify peptide identity and HPLC purity against the Certificate of Analysis; MDPs are short sequences where synthesis errors are detectable by mass spec.
- Reconstitute per documented SOP, prepare single-use aliquots, and avoid repeated freeze–thaw.
- Record lot numbers in any dataset comparing batches.
Frequently Asked Questions
What does MOTS-c stand for?
Mitochondrial open reading frame of the 12S rRNA type-c; it names the gene region encoding the 16-amino-acid peptide.
Where is MOTS-c encoded?
Within a short open reading frame of mitochondrial DNA’s 12S rRNA gene, making it a mitochondrial-derived peptide rather than a nuclear-encoded peptide.
How does MOTS-c activate AMPK?
Reported work links modulation of the folate cycle and de novo purine biosynthesis to AMPK activation in skeletal muscle; direct receptor identity remains an active research question.
What did the 2015 mouse study show?
MOTS-c treatment prevented age-related and high-fat-diet-induced insulin resistance and diet-induced obesity in mouse models (PMID 25738459).
Is MOTS-c an “exercise pill” for humans?
No. The exercise-mimetic label rests on rodent data; controlled human interventional evidence is not established.
How does MOTS-c compare with AICAR?
Both intersect AMPK metabolism: AICAR acts through ZMP nucleoside signaling; MOTS-c through folate/purine-linked mitochondrial signaling. Mechanism differs even where endpoints overlap.
What assays best test MOTS-c?
Glucose uptake, insulin signaling proxies, oxidation markers, p-AMPK and pathway metabolites in muscle-relevant cell or tissue models.
Where can research MOTS-c be obtained?
The linked product page supplies research-grade MOTS-c with purity documentation for laboratory accounts; personal-use claims are outside the research-only scope.
References
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015. https://pubmed.ncbi.nlm.nih.gov/25738459/
- MOTS-c: an equal opportunity insulin sensitizer (commentary on evidence boundaries). https://pmc.ncbi.nlm.nih.gov/articles/PMC6462348/
View research MOTS-c → https://hanpropeptides.com/product/mots-c/
Lab-tested research material: high-purity lyophilized vials, lot-specific Certificate of Analysis, third-party QC and worldwide shipping for research accounts. Laboratory research use only; not for human or veterinary administration; no therapeutic claims are made.
Article Schema (JSON-LD)
FAQPage Schema (JSON-LD)
The MOTS-c compound data file collects the sequence, molecular weight, CAS and the impurity routes worth watching for this compound on one page.
